Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We began analyzing https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-016-0725-1, but it redirected us to https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-016-0725-1. The analysis below is for the second page.

Title[redir]:
Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification | Breast Cancer Research | Full Text
Description:
Spatial heterogeneity in biomarker expression may impact breast cancer classification. The aims of this study were to estimate the frequency of spatial heterogeneity in biomarker expression within tumors, to identify technical and biological factors contributing to spatial heterogeneity, and to examine the impact of discordant biomarker status within tumors on clinical record agreement. Tissue microarrays (TMAs) were constructed using two to four cores (1.0 mm) for each of 1085 invasive breast cancers from the Carolina Breast Cancer Study, which is part of the AMBER Consortium. Immunohistochemical staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) was quantified using automated digital imaging analysis. The biomarker status for each core and for each case was assigned using clinical thresholds. Cases with core-to-core biomarker discordance were manually reviewed to distinguish intratumoral biomarker heterogeneity from misclassification of biomarker status by the automated algorithm. The impact of core-to-core biomarker discordance on case-level agreement between TMAs and the clinical record was evaluated. On the basis of automated analysis, discordant biomarker status between TMA cores occurred in 9 %, 16 %, and 18 % of cases for ER, PR, and HER2, respectively. Misclassification of benign epithelium and/or ductal carcinoma in situ as invasive carcinoma by the automated algorithm was implicated in discordance among cores. However, manual review of discordant cases confirmed spatial heterogeneity as a source of discordant biomarker status between cores in 2 %, 7 %, and 8 % of cases for ER, PR, and HER2, respectively. Overall, agreement between TMA and clinical record was high for ER (94 %), PR (89 %), and HER2 (88 %), but it was reduced in cases with core-to-core discordance (agreement 70 % for ER, 61 % for PR, and 57 % for HER2). Intratumoral biomarker heterogeneity may impact breast cancer classification accuracy, with implications for clinical management. Both manually confirmed biomarker heterogeneity and misclassification of biomarker status by automated image analysis contribute to discordant biomarker status between TMA cores. Given that manually confirmed heterogeneity is uncommon (<10 % of cases), large studies are needed to study the impact of heterogeneous biomarker expression on breast cancer classification and outcomes.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Social Networks

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 91,115,781 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure if the website is profiting.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cases, heterogeneity, cores, cancer, breast, status, biomarker, tumor, article, pubmed, discordant, study, intratumoral, receptor, clinical, google, scholar, expression, discordance, automated, agreement, manually, core, central, analysis, cas, tma, frequency, estrogen, record, tmas, case, confirmed, studies, carolina, staining, positive, data, research, impact, progesterone, manual, manuscript, tissue, invasive, chapel, hill, usa, negative, clin,

Topics {✒️}

springer nature author information authors additional file 1 tissue microarray cores sections state privacy rights discussion background heterogeneity estrogen receptor results 1309/pj7h-a52v-m3xb-v94y conclusions rights false-positive automated scores nature progesterone-receptor status methods study population multi-ethnic cohort study nuclear v9 algorithm membrane v9 algorithm author correspondence original author estrogen receptor heterogeneity translational pathology laboratory discordant estrogen receptor background hormone receptor-negative tumors smaller tumor size automated methods central tma results paraffin-embedded tumor blocks automated algorithm privacy choices/manage cookies participating pathology laboratories er estrogen receptor digital algorithms authors scientific editing content case-level her2 status tumor cellularity-weighted approach case-level positivity status progesterone receptor oestrogen receptor expression bmc community-based clinical study information human research ethics biomarker-negative invasive carcinoma her2-negative invasive tumor progesterone receptors reconsidered human breast tumours

Questions {❓}

  • Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports?
  • Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification
         description:Spatial heterogeneity in biomarker expression may impact breast cancer classification. The aims of this study were to estimate the frequency of spatial heterogeneity in biomarker expression within tumors, to identify technical and biological factors contributing to spatial heterogeneity, and to examine the impact of discordant biomarker status within tumors on clinical record agreement. Tissue microarrays (TMAs) were constructed using two to four cores (1.0 mm) for each of 1085 invasive breast cancers from the Carolina Breast Cancer Study, which is part of the AMBER Consortium. Immunohistochemical staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) was quantified using automated digital imaging analysis. The biomarker status for each core and for each case was assigned using clinical thresholds. Cases with core-to-core biomarker discordance were manually reviewed to distinguish intratumoral biomarker heterogeneity from misclassification of biomarker status by the automated algorithm. The impact of core-to-core biomarker discordance on case-level agreement between TMAs and the clinical record was evaluated. On the basis of automated analysis, discordant biomarker status between TMA cores occurred in 9 %, 16 %, and 18 % of cases for ER, PR, and HER2, respectively. Misclassification of benign epithelium and/or ductal carcinoma in situ as invasive carcinoma by the automated algorithm was implicated in discordance among cores. However, manual review of discordant cases confirmed spatial heterogeneity as a source of discordant biomarker status between cores in 2 %, 7 %, and 8 % of cases for ER, PR, and HER2, respectively. Overall, agreement between TMA and clinical record was high for ER (94 %), PR (89 %), and HER2 (88 %), but it was reduced in cases with core-to-core discordance (agreement 70 % for ER, 61 % for PR, and 57 % for HER2). Intratumoral biomarker heterogeneity may impact breast cancer classification accuracy, with implications for clinical management. Both manually confirmed biomarker heterogeneity and misclassification of biomarker status by automated image analysis contribute to discordant biomarker status between TMA cores. Given that manually confirmed heterogeneity is uncommon (<10 % of cases), large studies are needed to study the impact of heterogeneous biomarker expression on breast cancer classification and outcomes.
         datePublished:2016-06-28T00:00:00Z
         dateModified:2016-06-28T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13058-016-0725-1
         keywords:
            Automated algorithm
            Digital pathology
            Discordance
            Estrogen receptor
            HER2
            Immunohistochemistry
            Intratumoral heterogeneity
            Progesterone receptor
            Tissue microarray
            Cancer Research
            Oncology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-016-0725-1/MediaObjects/13058_2016_725_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-016-0725-1/MediaObjects/13058_2016_725_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-016-0725-1/MediaObjects/13058_2016_725_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-016-0725-1/MediaObjects/13058_2016_725_Fig4_HTML.gif
         isPartOf:
            name:Breast Cancer Research
            issn:
               1465-542X
            volumeNumber:18
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Emma H. Allott
               affiliation:
                     name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
                     address:
                        name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
                     name:University of North Carolina at Chapel Hill
                     address:
                        name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joseph Geradts
               affiliation:
                     name:Brigham & Women’s Hospital
                     address:
                        name:Department of Pathology, Brigham & Women’s Hospital, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xuezheng Sun
               affiliation:
                     name:University of North Carolina at Chapel Hill
                     address:
                        name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephanie M. Cohen
               affiliation:
                     name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
                     address:
                        name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gary R. Zirpoli
               affiliation:
                     name:Roswell Park Cancer Institute
                     address:
                        name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thaer Khoury
               affiliation:
                     name:Roswell Park Cancer Institute
                     address:
                        name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wiam Bshara
               affiliation:
                     name:Roswell Park Cancer Institute
                     address:
                        name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mengjie Chen
               affiliation:
                     name:University of North Carolina at Chapel Hill
                     address:
                        name:Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
                     name:University of North Carolina at Chapel Hill
                     address:
                        name:Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark E. Sherman
               affiliation:
                     name:Division of Cancer Prevention, National Cancer Institute
                     address:
                        name:Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Julie R. Palmer
               affiliation:
                     name:Slone Epidemiology Center, Boston University
                     address:
                        name:Slone Epidemiology Center, Boston University, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christine B. Ambrosone
               affiliation:
                     name:Roswell Park Cancer Institute
                     address:
                        name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andrew F. Olshan
               affiliation:
                     name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
                     address:
                        name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
                     name:University of North Carolina at Chapel Hill
                     address:
                        name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Melissa A. Troester
               affiliation:
                     name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
                     address:
                        name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
                     name:University of North Carolina at Chapel Hill
                     address:
                        name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification
      description:Spatial heterogeneity in biomarker expression may impact breast cancer classification. The aims of this study were to estimate the frequency of spatial heterogeneity in biomarker expression within tumors, to identify technical and biological factors contributing to spatial heterogeneity, and to examine the impact of discordant biomarker status within tumors on clinical record agreement. Tissue microarrays (TMAs) were constructed using two to four cores (1.0 mm) for each of 1085 invasive breast cancers from the Carolina Breast Cancer Study, which is part of the AMBER Consortium. Immunohistochemical staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) was quantified using automated digital imaging analysis. The biomarker status for each core and for each case was assigned using clinical thresholds. Cases with core-to-core biomarker discordance were manually reviewed to distinguish intratumoral biomarker heterogeneity from misclassification of biomarker status by the automated algorithm. The impact of core-to-core biomarker discordance on case-level agreement between TMAs and the clinical record was evaluated. On the basis of automated analysis, discordant biomarker status between TMA cores occurred in 9 %, 16 %, and 18 % of cases for ER, PR, and HER2, respectively. Misclassification of benign epithelium and/or ductal carcinoma in situ as invasive carcinoma by the automated algorithm was implicated in discordance among cores. However, manual review of discordant cases confirmed spatial heterogeneity as a source of discordant biomarker status between cores in 2 %, 7 %, and 8 % of cases for ER, PR, and HER2, respectively. Overall, agreement between TMA and clinical record was high for ER (94 %), PR (89 %), and HER2 (88 %), but it was reduced in cases with core-to-core discordance (agreement 70 % for ER, 61 % for PR, and 57 % for HER2). Intratumoral biomarker heterogeneity may impact breast cancer classification accuracy, with implications for clinical management. Both manually confirmed biomarker heterogeneity and misclassification of biomarker status by automated image analysis contribute to discordant biomarker status between TMA cores. Given that manually confirmed heterogeneity is uncommon (<10 % of cases), large studies are needed to study the impact of heterogeneous biomarker expression on breast cancer classification and outcomes.
      datePublished:2016-06-28T00:00:00Z
      dateModified:2016-06-28T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13058-016-0725-1
      keywords:
         Automated algorithm
         Digital pathology
         Discordance
         Estrogen receptor
         HER2
         Immunohistochemistry
         Intratumoral heterogeneity
         Progesterone receptor
         Tissue microarray
         Cancer Research
         Oncology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-016-0725-1/MediaObjects/13058_2016_725_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-016-0725-1/MediaObjects/13058_2016_725_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-016-0725-1/MediaObjects/13058_2016_725_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-016-0725-1/MediaObjects/13058_2016_725_Fig4_HTML.gif
      isPartOf:
         name:Breast Cancer Research
         issn:
            1465-542X
         volumeNumber:18
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Emma H. Allott
            affiliation:
                  name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
                  address:
                     name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
                  name:University of North Carolina at Chapel Hill
                  address:
                     name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joseph Geradts
            affiliation:
                  name:Brigham & Women’s Hospital
                  address:
                     name:Department of Pathology, Brigham & Women’s Hospital, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xuezheng Sun
            affiliation:
                  name:University of North Carolina at Chapel Hill
                  address:
                     name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephanie M. Cohen
            affiliation:
                  name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
                  address:
                     name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gary R. Zirpoli
            affiliation:
                  name:Roswell Park Cancer Institute
                  address:
                     name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thaer Khoury
            affiliation:
                  name:Roswell Park Cancer Institute
                  address:
                     name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wiam Bshara
            affiliation:
                  name:Roswell Park Cancer Institute
                  address:
                     name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mengjie Chen
            affiliation:
                  name:University of North Carolina at Chapel Hill
                  address:
                     name:Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
                  name:University of North Carolina at Chapel Hill
                  address:
                     name:Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark E. Sherman
            affiliation:
                  name:Division of Cancer Prevention, National Cancer Institute
                  address:
                     name:Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Julie R. Palmer
            affiliation:
                  name:Slone Epidemiology Center, Boston University
                  address:
                     name:Slone Epidemiology Center, Boston University, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christine B. Ambrosone
            affiliation:
                  name:Roswell Park Cancer Institute
                  address:
                     name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andrew F. Olshan
            affiliation:
                  name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
                  address:
                     name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
                  name:University of North Carolina at Chapel Hill
                  address:
                     name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Melissa A. Troester
            affiliation:
                  name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
                  address:
                     name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
                  name:University of North Carolina at Chapel Hill
                  address:
                     name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research
      issn:
         1465-542X
      volumeNumber:18
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
      address:
         name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill
      address:
         name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:Brigham & Women’s Hospital
      address:
         name:Department of Pathology, Brigham & Women’s Hospital, Boston, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill
      address:
         name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
      address:
         name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:Roswell Park Cancer Institute
      address:
         name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
         type:PostalAddress
      name:Roswell Park Cancer Institute
      address:
         name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
         type:PostalAddress
      name:Roswell Park Cancer Institute
      address:
         name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill
      address:
         name:Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill
      address:
         name:Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:Division of Cancer Prevention, National Cancer Institute
      address:
         name:Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
         type:PostalAddress
      name:Slone Epidemiology Center, Boston University
      address:
         name:Slone Epidemiology Center, Boston University, Boston, USA
         type:PostalAddress
      name:Roswell Park Cancer Institute
      address:
         name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
         type:PostalAddress
      name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
      address:
         name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill
      address:
         name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
      address:
         name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill
      address:
         name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Emma H. Allott
      affiliation:
            name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
            address:
               name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
            name:University of North Carolina at Chapel Hill
            address:
               name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Joseph Geradts
      affiliation:
            name:Brigham & Women’s Hospital
            address:
               name:Department of Pathology, Brigham & Women’s Hospital, Boston, USA
               type:PostalAddress
            type:Organization
      name:Xuezheng Sun
      affiliation:
            name:University of North Carolina at Chapel Hill
            address:
               name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Stephanie M. Cohen
      affiliation:
            name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
            address:
               name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Gary R. Zirpoli
      affiliation:
            name:Roswell Park Cancer Institute
            address:
               name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
               type:PostalAddress
            type:Organization
      name:Thaer Khoury
      affiliation:
            name:Roswell Park Cancer Institute
            address:
               name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
               type:PostalAddress
            type:Organization
      name:Wiam Bshara
      affiliation:
            name:Roswell Park Cancer Institute
            address:
               name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
               type:PostalAddress
            type:Organization
      name:Mengjie Chen
      affiliation:
            name:University of North Carolina at Chapel Hill
            address:
               name:Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
            name:University of North Carolina at Chapel Hill
            address:
               name:Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Mark E. Sherman
      affiliation:
            name:Division of Cancer Prevention, National Cancer Institute
            address:
               name:Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
               type:PostalAddress
            type:Organization
      name:Julie R. Palmer
      affiliation:
            name:Slone Epidemiology Center, Boston University
            address:
               name:Slone Epidemiology Center, Boston University, Boston, USA
               type:PostalAddress
            type:Organization
      name:Christine B. Ambrosone
      affiliation:
            name:Roswell Park Cancer Institute
            address:
               name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
               type:PostalAddress
            type:Organization
      name:Andrew F. Olshan
      affiliation:
            name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
            address:
               name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
            name:University of North Carolina at Chapel Hill
            address:
               name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Melissa A. Troester
      affiliation:
            name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
            address:
               name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
            name:University of North Carolina at Chapel Hill
            address:
               name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Department of Pathology, Brigham & Women’s Hospital, Boston, USA
      name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
      name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
      name:Department of Pathology, Roswell Park Cancer Institute, Buffalo, USA
      name:Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
      name:Slone Epidemiology Center, Boston University, Boston, USA
      name:Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, USA
      name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, USA

External Links {🔗}(289)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

3.38s.